Lea Leiv's most recent trade in Corvus Pharmaceuticals Inc was a trade of 300,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | Lea Leiv | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Lea Leiv | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Leiv Lea | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 13 Dec 2022 | 30,000 | 129,238 (0%) | 0% | 0.7 | 22,275 | Common Stock |
| Corvus Pharmaceuticals Inc | Leiv Lea | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 13 Dec 2022 | 4,000 | 133,238 (0%) | 0% | 0.8 | 3,364 | Common Stock |
| Corvus Pharmaceuticals Inc | Leiv Lea | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Leiv Lea | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 16 Mar 2022 | 35,160 | 85,360 (0%) | 0% | 1.5 | 54,146 | Common Stock |
| Corvus Pharmaceuticals Inc | Leiv Lea | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.65 per share. | 16 Mar 2022 | 13,878 | 99,238 (0%) | 0% | 1.7 | 22,899 | Common Stock |
| Corvus Pharmaceuticals Inc | Leiv Lea | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Leiv Lea | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) |